sábado, 16 de marzo de 2013

National Guideline Clearinghouse | BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.

full-text ►
National Guideline Clearinghouse | BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.


National Guideline Clearinghouse (NGC)

March 11, 2013


New This Week

Guideline Title
BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis.
 
Bibliographic Source(s)
Bukhari M, Abernethy R, Deighton C, Ding T, Hyrich K, Lunt M, Luqmani R, Kiely P, Bosworth A, Ledingham J, Ostor A, Gadsby K, McKenna F, Finney D, Dixey J, BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. London (England): British Society for Rheumatology; 2011. 9 p. [52 references]
 
Guideline Status
This is the current release of the guideline.

No hay comentarios:

Publicar un comentario